Antidepressants Not Found to 'Benefit Dementia Patients'

Article

Dementia sufferers do not benefit from being administered specific antidepressants, and in fact, the drugs may do more harm than good.

According to recent research, dementia sufferers do not benefit from being administered specific antidepressants. In fact, these drugs could put the patients at greater risk due to a variety of possible side-effects.

The study, which was conducted by a team in the United Kingdom, was a randomized drug trial which focused on antidepressant drugs in patients suffering from dementia. The researchers focused on the difference in depression symptoms in dementia patients who received mirtazapine, sertraline, and placebo pills.

They discovered that there was no reduction in symptoms of depression in the dementia patients who received the antidepressants.

"Analysis of the data suggests clearly that antidepressants, given with normal care, are not clinically effective," stated the report. "This finding implies a need to change the present clinical practice."

Henry Brodaty of New South Wales University's School of Psychiatry reported that the probe was the largest of its kind into the impact of antidepressants on dementia symptoms.

The drugs, however, are still effective for some elderly people with depression, he added.

This study was published in the Lancet.

Recent Videos
Boadie Dunlop, MD, Weighs in on FDA Advisory Vote on Lykos’ MDMA
Bhanu Prakash Kolla, MBBS, MD: Treating Sleep with Psychiatric Illness
Awaiting FDA Decision on MDMA Assisted Therapy, with Bessel van der Kolk, MD
Bessel van der Kolk, MD: The Future of MDMA Assisted Therapy in PTSD
Bessel van der Kolk, MD: What MDMA-Assisted Therapy Taught us About PTSD
Why Are Adult ADHD Cases Climbing?
How to Adequately Screen for and Treat Cognitive Decline in Primary Care
Depression Screening: Challenges and Solutions at the Primary Care Level
Tailoring Chest Pain Diagnostics to Patients, with Kyle Fortman, PA-C, MBA
James R. Kilgore, DMSc, PhD, PA-C: Cognitive Decline Diagnostics
© 2024 MJH Life Sciences

All rights reserved.